Biotechnology in the twenty-first century has impacted almost every aspect of human life from medicine to food, fuel and environmental control with major implications on present and future economic expectations. The emergence of new markets has led to the spread of biotechnology well beyond the borders of a few countries, creating a global enterprise.
The enablers and barriers to the future sustained global success in biotechnology include innovation in technology, economic and regulatory frameworks as well as social, political and environmental factors.
This conference attempts to address these issues and examines the ways that industry and academia could harness the future advances in biotechnology.
Poster submissions are invited. Please send a maximum one A4 page abstract by Friday
4 October 2013 to firstname.lastname@example.org with the title 'Barriers and Enablers of
Biotechnology - poster abstract submission' in the email subject line.
Nadine (send an email)
Posters: Friday, October 4, 2013
Prof Ray Hill, Imperial College London
Dr Khosrow Shami, Source Bioscience
Prof Eli Keshavarz-Moore, UCL
Dr Namdar Baghaei Yazdi, Biotech Consultants Ltd
Prof Steve Arlington, PwC Consulting
Dr Vicki Salmon, IP asset LLP
Dr Tony Bradshaw, HealthTech & Medicines KTN
Prof Stephen Hughes, University of Exeter
The pharmaceutical industry - need for a new business model
Enabling science is good business: a case study
The role of bioprocessing in delivering a successful business
The role of SMEs in global markets
Pharma 2020 - From vision to decision
Patents - do they enhance or inhibit market access? Busting myths
Leveraging (or translating) UK Biopharma capability for global benefit
Architectures of participation
Sponsored by Source Bioscience